Skip to main content
NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
BL

BioAge Labs Inc. (BIOA)

NASDAQ • Healthcare

$9.17
-$0.23 (-2.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$9.38
Previous Close$9.17
Day Range$9.02 - $9.4
Avg. Volume (3M)537.9K
Market Cap$331.3M
52 Week Range
$4.68$25.96
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$2.4M100%
Gross Profitminus cost of goods$2.4M100%

Fundamentals & Financials

Revenue (TTM)
$10.3M
Net Income (TTM)
-$94.4M
EPS (TTM)
-$2.38
ROA (TTM)
-23.8%
Current Ratio
17.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+13.3%Q1 2026-$0.72
+18.7%Q2 2026-$0.52
+4.5%Q3 2026-$0.58
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +4.5%

BioAge Labs beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 6, as revenue rose 1.6% to about $2.5 million, topping about $1.5 million of consensus by 63.7%, and EPS of -$0.58 beat the -$0.61 estimate by 4.5% while improving 3.3% from -$0.60 a year ago. Gross profit was $0, leaving gross margin near 0%, and operating loss came to about $29.3 million with operating margin around -1,197%. Net income was a loss of about $26.1 million, down 21.0% from a loss of $21.6 million a year ago, and operating cash flow was negative $43.3 million. Consensus for the next period calls for EPS of -$0.72.

View full earnings history

About BioAge Labs Inc.

BioAge Labs Inc. is a NASDAQ-listed Biotechnology company in the healthcare sector that develops therapeutic product candidates for metabolic diseases. In qualitative terms, it is a clinical-stage biotech business. BioAge Labs identifies drug targets from molecular changes associated with aging and advances those findings into medicines.

Name
BioAge Labs Inc.
CEO
Kristen Fortney
Website
bioagelabs.com
Industry
Healthcare
Year Founded
2015
Employees
61

Today's Snapshot

AI-generated

BIOA is trading 4.2% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (490.0K)

198.1K

vs S&P 500 Today

Strong Underperformance

-3.68%

Updated: September 10, 2026 at 17:05 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
BIOA’s technical picture is strongly bearish: the stock trades well below its short-, medium- and long-term moving averages and OBV shows distribution while VWAP and pivots sit above the market. Trend strength is pronounced to the downside with a high ADX, momentum measures are weak—CCI is deeply negative and MACD is non-supportive—and volatility is elevated at roughly a high-single-digit percent ATR. A few oscillators are near oversold levels, but they have not yet altered the dominant trend. Technical takeaway: Strong sell bias driven by clear downtrend and heavy selling pressure.
All signals
  • EMA (5 indicators)$9.47 - $15.30
    Sell
  • RSI (14)30.53
    Neutral
  • Stochastic %K (14, 3, 3)9.96
    Buy
  • MACD Level (12, 26)-1.51
    Neutral

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.73-7.0%
AVIRAtea Pharmaceuticals, Inc.
$5.27-7.2%
EDITEditas Medicine, Inc.
$2.77-8.6%
CGCCanopy Growth Corporation
$0.93-2.9%
ACBAurora Cannabis Inc.
$3.76-3.2%
HUMAHumacyte, Inc.
$0.58-2.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.